do glp 1 agonists cause muscle loss Using glp-1 receptor for weight reduction in dystrophy patients Weight loss with GLP-1 medicines
Description
Duration of intervention was 12, 26, 40 and 52 weeks in one, one, three and two studies, respectively
Furthermore, this patient subgroup reported increased adverse events related to weight loss (ROR = 10.85, 95% CI 9.1212.91) and metabolic disturbances
"You'd think that would be a basic question because how do you know what the true market is if you haven't even asked how big it is?" Rosebush says
Since then, several others have followed, including dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), semaglutide (Ozempic, Wegovy), and the latest FDA-approved medication, tirzepatide (Mounjaro, Zepbound)
